Page 215 - Effective healthcare cost containment policies Using the Netherlands as a case study - Niek W. Stadhouders
P. 215

General Discussion
Newhouse, J. P. (2004). Consumer-directed health plans and the RAND Health Insurance Experiment. Health Affairs 23, 107-113.
Newhouse, J. P., Manning, W. G., Morris, C. N., Orr, L. L., Duan, N., Keeler, E. B., Leibowitz, A., Marquis, K. H., Marquis, M. S., and Phelps, C. E. (1981). Some interim results from a controlled trial of cost sharing in health insurance. New England Journal of Medicine 305, 1501-1507.
Nguyen, N. X. (1996). Physician volume response to price controls. Health Policy 35, 189-204.
Nimdet, K., Chaiyakunapruk, N., Vichansavakul, K., and Ngorsuraches, S. (2015). A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
PLoS One 10, e0122760.
Nixon, J., and Ulmann, P. (2006). The relationship between health care expenditure and health outcomes.
The European Journal of Health Economics 7, 7-18.
NZa (2017a). "marktscan zorgverzekeringsmarkt 2017." NZa, Utrecht.
NZA (2017b). "Marktscan Zorgverzekeringsmarkt 2017." NZa, Utrecht.
O’Mahony, J. F., and Coughlan, D. (2015). The Irish Cost-Effectiveness Threshold: Does it Support
Rational Rationing or Might it Lead to Unintended Harm to Ireland’s Health System?
PharmacoEconomics 34, 5-11.
Ochalek, J., Lomas, J., Claxton, K., Economic, U. o. Y. D. o., and Studies, R. (2015). "Cost per DALY
averted thresholds for low-and middle-income countries: evidence from cross country data."
Centre for Health Economics, University of York.
OECD (2011). Health care systems: getting more value for money. Economics Department Policy Notes 2. OECD (2015a). Health spending (indicator).
OECD (2015b). OECD Better life index. Vol. 2015.
OECD (2017a). Health Expenditure-Aggregated data. Retrieved October 2017.
OECD (2017b). "Tackling Wasteful Spending on Health."
OECD/WHO/Eurostat (2011). "A System of Health Accounts," OECD Publishing.
Okma, K. G., Marmor, T. R., and Oberlander, J. (2011). Managed competition for Medicare? Sobering
lessons from the Netherlands. New England Journal of Medicine 365, 287-289.
Olsen, O. (2002). The Cochrane Non-Randomised Studies Methods Group (NRSMG). The Cochrane
Collaboration.
Or, Z., Cases, C., Lisac, M., Vrangbæk, K., Winblad, U., and Bevan, G. (2010). Are health problems
systemic? Politics of access and choice under Beveridge and Bismarck systems. Health
Economics, Policy and Law 5, 269-293.
Osborn, R., Squires, D., Doty, M. M., Sarnak, D. O., and Schneider, E. C. (2016). In new survey of eleven
countries, US adults still struggle with access to and affordability of health care. Health Affairs 35,
2327-2336.
Owusu-Frimpong, N., Nwankwo, S., and Dason, B. (2010). Measuring service quality and patient
satisfaction with access to public and private healthcare delivery. In "International Journal of
Public Sector Management", Vol. 23, pp. 203-220.
Ozminkowski, R. J., Dunn, R. L., Goetzel, R. Z., Cantor, R. I., Murnane, J., and Harrison, M. (1999). A
return on investment evaluation of the Citibank, NA, health management program. American
Journal of Health Promotion 14, 31-43.
Pammolli, F., Riccaboni, M., and Magazzini, L. (2012). The sustainability of European health care systems:
beyond income and aging. The European Journal of Health Economics 13, 623-634.
Pane, G. A., and Taliaferro, E. H. (1994). Health care cost containment: An overview of policy options.
Annals of Emergency Medicine 23, 103-108.
Pappa, E., and Niakas, D. (2006). Assessment of health care needs and utilization in a mixed public-private
system: the case of the Athens area. In "BMC health services research", Vol. 6, pp. 1.
Park, C. M., Lee, K. S., Han, E., and Kim, D. S. (2016). Effects of delisting nonprescription combination
drugs on health insurance expenditures for pharmaceuticals in Korea. Health Policy.
Parsonage, M., and Neuburger, H. (1992). Discounting and health benefits. Health economics 1, 71-76. Paulden, M. (2016). The determinants of change in the cost-effectiveness threshold. In "16th Biennial
European Conference". Smdm.
Pavelescu, F.-M. (2011). Some aspects of the translog production function estimation. Romanian Journal of
Economics 32, 41.
Pawson, R., Greenhalgh, T., Harvey, G., and Walshe, K. (2005). Realist review–a new method of
systematic review designed for complex policy interventions. In "Journal of health services research & policy", Vol. 10, pp. 21-34.
 207















































   213   214   215   216   217